MediTox

MediTox is a GLP-certified CRO with experience in variety of compounds and therapeutic areas, capable to conduct experiments and studies in full compliance with GLP standards and another international guidelines (EMA/ICH, VICH, OECD, FDA, ISO10993), providing core range of nonclinical studies supporting phases I – III of clinical trials and/or registration of human drugs, medical device and food additives and safety/BEQ/efficacy studies for registration of veterinary drugs and feed additives.

Summary of products/services
MediTox is a GLP-certified CRO having strong experience in
– MTD, DRF, pilot, proof-of-concept studies (rodents, non-rodents)
– Acute, sub-acute, subchronic, chronic toxicity studies (OECD, ICH/VICH, EFSA, rodents, – non-rodents)
– Medical device biocompatibility including implantation (ISO 10993, rodents, non-rodents)
– Genetic tox studies (OECD, ICH, ISO 10993. in vitro, in vivo)
– BA/BEQ/TK studies (OECD, ICHS, VICH, rodents, non-rodents)
– TAS, BEQ studies (VICH, dogs, cats, rabbits)
– Local effect (ICH, OECD, ISO 10993, Irritation, sensitization, local tolerance)
– Non-clinical safety, safety pharmacology (ICH)
– Medical device biocompatibility (ISO 10993, rodents, non-rodents)
– Feed and feed additives testing (EFSA, rodents, non-rodents)
– Experimental models available: chronic glaucoma (dog), arthritis (dog)